Recently, the U.S. Food & Drug Administration (FDA) began investigating a possible link between osteoporosis drugs and hip fracture.
Which drugs have been linked to hip fractures?
Millions of women in the U.S. that suffer from osteoporosis rely on bisphosphonates to slow bone loss. However, the FDA is currently investigating whether these medications, promoted to reduce the risk of fractures can actually increase the risk of hip fractures. These medications include:
- Actonel (risedronate)
- Aredia (pamidronate)
- Boniva (ibandronate)
- Fosomax (alendronate)
- Reclast (zoledronic acid)
- Zometa (zoledronic acid)
Most alarming is that the fractures being reported are not just among the elderly. Younger, active women are experiencing spontaneous fractures doing simple activities such as jumping rope. Hip fractures are extremely dangerous because of the high rate of mortality in the six months. The U.S. Department of Health and Human Services, estimates that as many as 20% of hip fracture patients die within 6 months.